PRIMECAP MANAGEMENT CO/CA/PRIMECAP MANAGEMENT CO/CA/

Institutional investor · Portfolio as of Q1 2019

Top Holdings292 positions

Checking export access…
Activity:

Eli Lilly and Company

43.2M$5.6B4.1%$104.77+12.74%
2 qtrssince 2018-Q4
Decreased
0

Adobe Inc.

19.3M$5.2B3.8%$226.24+17.79%
2 qtrssince 2018-Q4
Decreased
0

Microsoft Corporation

37.9M$4.5B3.3%$94.43+16.61%
2 qtrssince 2018-Q4
Decreased
0

SOUTHWEST AIRLS CO

73.7M$3.8B2.8%$41.94+12.02%
2 qtrssince 2018-Q4
Decreased
0

Amgen Inc.

19M$3.6B2.7%$153.91-1.65%
2 qtrssince 2018-Q4
Decreased
0

Texas Instruments Incorporated

33.4M$3.5B2.6%$76.19+13.10%
2 qtrssince 2018-Q4
Decreased
0

BIOGEN INC

14.6M$3.4B2.5%$300.92-21.45%
2 qtrssince 2018-Q4
Decreased
0

UNITED AIRLS HLDGS INC

38.2M$3B2.2%$83.73-4.72%
2 qtrssince 2018-Q4
Decreased
0
BABABABA
ADR

ALIBABA GROUP HLDG LTD

15.3M$2.8B2.0%$128.99+33.11%
2 qtrssince 2018-Q4
Decreased
0

FEDEX CORP

15.1M$2.7B2.0%$113.18+12.87%
2 qtrssince 2018-Q4
Decreased
0

Alphabet Inc.

2.2M$2.6B1.9%$51.76+12.61%
2 qtrssince 2018-Q4
Increased
50

Alphabet Inc.

2.1M$2.5B1.8%$51.29+13.30%
2 qtrssince 2018-Q4
Decreased
0

MICRON TECHNOLOGY INC

57.8M$2.4B1.8%$30.94+30.26%
2 qtrssince 2018-Q4
Decreased
0

NetApp, Inc.

33.9M$2.4B1.7%$48.51+16.98%
2 qtrssince 2018-Q4
Decreased
0

JPMorgan Chase & Co.

23.2M$2.3B1.7%$78.71+4.54%
2 qtrssince 2018-Q4
Increased
50
NVSNVS
ADR

NOVARTIS AG

23.9M$2.3B1.7%$57.67+14.93%
2 qtrssince 2018-Q4
Increased
52
AZNAZN
ADR

ASTRAZENECA PLC

56.3M$2.3B1.7%$63.12+8.86%
2 qtrssince 2018-Q4
Increased
50

AIRBUS GROUP SE

17.1M$2.3B1.7%——
2 qtrssince 2018-Q4
Decreased
0

Wells Fargo & Company

46M$2.2B1.6%$37.37+5.75%
2 qtrssince 2018-Q4
Increased
51

AMERICAN AIRLINES GROUP INC

68.8M$2.2B1.6%$31.60-0.82%
2 qtrssince 2018-Q4
Decreased
0
$135.9B
AUM
292
Positions
Q1 2019
Filing
HI score · 3.5/5
Quarterly 13F Value Change
Not enough history yet
Activity profile
$ moved · Q1'19
New3%Increased27%Decreased68%Exited2%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg <1 quarter
<1Q2%1-4Q98%1-2Y0%2Y+0%

PRIMECAP MANAGEMENT CO/CA/ manages $135.9B across 292 positions as of Q1 2019. Top holdings: LLY (4.1%), ADBE (3.8%), MSFT (3.3%). Fund DNA: Steady Compounder. HoldingsIntel Score: 3.5/5.0.

Q1 2019 Summary

Active quarter - 6 new positions, 5 exits, 71 increased. Top move: NVS (INCREASED, conviction 52). Portfolio: $135.9B across 292 positions.

Top holdings by portfolio weight

Total AUM$136B
LLY4.13%
ADBE3.79%
MSFT3.29%
LUV2.81%
AMGN2.66%
TXN2.60%
BIIB2.54%
UAL2.24%
BABA2.05%
FDX2.01%
Other1.90%

Portfolio allocation by GICS sector

Sectors11
Technology29.07%
Healthcare22.49%
Industrials14.54%
Unknown10.64%
Consumer Cyclical9.07%
Financial Services8.05%
Communication Services4.38%
Energy0.89%
Basic Materials0.45%
Consumer Defensive0.37%
Other0.03%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Technology, Healthcare, Industrials
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Strong(3.5 / 5.0)
Holdings P&L68
Conviction36
Concentration64
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
COPCOPConocoPhillips
Q4 2024 → Q2 2026+7.3M shares+$749.8M
7Q
SCHWSCHWCharles Schwab Corp
Q4 2024 → Q2 2026+24.1M shares+$2.3B
7Q
USFDUSFDUS FOODS HLDG CORP
Q4 2024 → Q2 2026+3.7M shares+$389.3M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used